Table 3. Comparison of the laboratory findings of children during the pre-COVID-19 period and COVID-19 period.

Parameters	Total, No.	pre-COVID-19 period	COVID-19 period	P value
FBS, mg/dL	114	96.0 ± 9.1	95.6 ± 6.1	0.631
HbA1c, %	115	5.4 ± 0.2	5.4 ± 0.2	0.235
Insulin, μIU/mL	98	15.8 ± 14.1	18.5 ± 10.3	0.095
HOMA-IR	98	3.9 ± 4.5	4.4 ± 2.6	0.325
AST, mg/dL	126	25.7 ± 6.5	24.1 ± 8.8	0.007
ALT, mg/dL	126	17.7 ± 11.9	19.3 ± 21.5	0.203
Uric acid, mg/dL	114	5.0 ± 1.3	5.3 ± 1.4	< 0.001
Total cholesterol, mg/dL	109	167.8 ± 27.6	171.0 ± 29.4	0.058
Triglycerides, mg/dL	108	88.6 ± 48.3	105.8 ± 56.0	< 0.001
HDL-C, mg/dL	108	58.5 ± 10.9	58.9 ± 9.5	0.487
LDL-C, mg/dL	60	94.0 ± 27.4	100.2 ± 33.3	0.002
25OHD, mg/dL	112	23.8 ± 8.2	18.9 ± 6.8	< 0.001

Values are presented as mean ± standard deviation.

COVID-19 = coronavirus disease 2019, 25OHD = calcidiol, ALT = alanine aminotransferase, AST = aspartate aminotransferase, FBS = fasting blood sugar, HbA1c = glycated hemoglobin, HOMA-IR = homeostatic model assessment for insulin resistance, HDL-C = high-density lipoprotein-cholesterol, LDL-C = low-density lipoprotein-cholesterol.